GSK plc
GSK
$40.32
$0.270.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.26B | 3.17B | 5.09B | 5.65B | 6.13B |
| Total Depreciation and Amortization | 3.00B | 3.26B | 2.76B | 2.52B | 2.60B |
| Total Amortization of Deferred Charges | 270.22M | 252.16M | 252.16M | 252.16M | 252.16M |
| Total Other Non-Cash Items | 1.50B | -412.00M | -257.30K | 373.94M | 494.55M |
| Change in Net Operating Assets | 376.04M | 3.12B | 1.29B | 831.06M | -1.00B |
| Cash from Operations | 8.40B | 9.39B | 9.39B | 9.62B | 8.47B |
| Capital Expenditure | -1.79B | -1.70B | -1.68B | -1.67B | -1.64B |
| Sale of Property, Plant, and Equipment | 83.21M | 13.79M | 26.41M | 27.65M | 34.88M |
| Cash Acquisitions | -1.05B | -964.85M | -1.04B | -2.75B | -1.84B |
| Divestitures | -22.94M | -25.23M | -23.86M | 65.08M | 61.60M |
| Other Investing Activities | 1.17B | 2.84B | 3.21B | 2.64B | 1.39B |
| Cash from Investing | -1.60B | 164.06M | 493.65M | -1.68B | -1.99B |
| Total Debt Issued | 1.34B | -1.41B | -2.02B | -329.00M | 223.00M |
| Total Debt Repaid | -2.73B | -2.99B | -2.87B | -2.98B | -2.79B |
| Issuance of Common Stock | 20.00M | 21.00M | 20.00M | 22.00M | 12.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -2.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.12B | -3.04B | -2.97B | -2.84B | -2.79B |
| Other Financing Activities | -910.00M | -698.00M | -770.00M | -837.00M | -837.00M |
| Cash from Financing | -6.03B | -9.42B | -10.04B | -8.00B | -7.04B |
| Foreign Exchange rate Adjustments | -69.46M | -120.66M | -47.30M | -108.55M | -122.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 698.87M | 17.39M | -199.30M | -169.60M | -682.07M |
